Management of Type 1 Supracondylar Humeral Fractures
Trauma | Elbow FractureThis study compares the clinical outcomes of treating pediatric Type 1 supracondylar fracture with a long arm soft cast and no clinical or radiographic follow-up versus the standard treatment in a long arm cast with clinical follow-up.
This is the first multicenter randomized control trial looking at the clinical effectiveness, safety and parental satisfaction of managing inherently stable Type I supracondylar fractures without clinical or radiological follow-up. If found to be safe; children can be managed effectively without in-person follow-up, freeing clinic appointments to children on the waiting list and in these COVID times avoiding unnecessary contacts.
null
Participation Requirements
-
Sex:
ALL -
Eligible Ages:
3 to 8
Participation Criteria
Inclusion Criteria:
- Children 3 to 8 years of age with a diagnosed supracondylar humerus fracture Type 1 (undisplaced).
Exclusion Criteria:
* Children diagnosed with a Type II or III supracondylar fracture or any other elbow injury
* Children who present with neurovascular compromise associated with their fracture
* Children who have been previously diagnosed with a metabolic or structural bone disease that predisposes them to fractures
Diagnostic criteria for a Type I supracondylar fracture will include either:
A) A clear fracture line through the supracondylar region with no displacement or angulation of the distal humerus (including a normal anterior humeral line that intersects the capitellum) OR B) The absence of a clear fracture line but history of an extension injury to the arm AND tenderness at the elbow AND local swelling AND presence of a posterior fat pad on plain radiographs.
Study Location
BC Children's Hospital
BC Children's HospitalVancouver, British Columbia
Canada
Contact Study Team
Kishore Mulpuri, FRCSC
Anthony Cooper, FRCSC
Paul Enarson, MD, PhD, FRCPC
- Study Sponsored By
- University of British Columbia
- Participants Required
- More Information
- Study ID:
NCT04642807